Akèy › Dematit atopik (Ekzema) › New York › New York City
Etid klinik pou Dematit atopik (Ekzema) nan New York City, NY
13 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Ap rekriteFaz 1Volontè an sante akeyi
- OptiSkin Medical, New York
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Enveda Investigative Site, New York
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Ap rekriteFaz 2
- Investigational Site, New York
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Ap rekrite
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Sadick Research Group, LLC, New York
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Inmagene Site 21, New York
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Ap rekriteFaz 3
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Ap rekriteFaz 1
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Ap rekriteFaz 2
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- Sadick Research Group, New York
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Ap rekriteEtid obsèvasyon
- Galderma Investigational Site - 7051, New York
- Galderma Investigational Site 7109, New York
- Galderma Investigational Site 8279, New York
Allergy and Immunology Natural History Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Ap rekriteFaz 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Pfizer, New York
Etid Dematit atopik (Ekzema) nan lòt vil
- Los Angeles, CA11 etid
- Washington, DC11 etid
- San Antonio, TX10 etid
- San Diego, CA10 etid
- Birmingham, AL9 etid
- Miami, FL9 etid
- Dallas, TX8 etid
- Huntington Beach, CA8 etid
- Sacramento, CA8 etid
- Troy, MI8 etid
- Indianapolis, IN7 etid
- Tampa, FL7 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.